<th id="grzca"></th>
<b id="grzca"><menuitem id="grzca"></menuitem></b>

<th id="grzca"></th>
<strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    全國(guó)服務(wù)咨詢熱線:

    18438616290

    Products產(chǎn)品中心
    首頁(yè) > 產(chǎn)品中心 > 生化試劑 > 小分子化合物 > abs47027950Terconazole 67915-31-5

    Terconazole 67915-31-5

    簡(jiǎn)要描述:Terconazole 67915-31-5
    Arecoline is a muscarinic acetylcholine receptor agonist. Arecoline induces ADP ribosylation of histones and chromatid relaxation in spleen and bone marrow cells.

    • 產(chǎn)品型號(hào):abs47027950
    • 廠商性質(zhì):生產(chǎn)廠家
    • 更新時(shí)間:2026-01-08
    • 訪  問(wèn)  量:667

    詳細(xì)介紹

    品牌absinCAS67915-31-5
    分子式C26H31Cl2N5O3純度≥98%
    分子量532.46貨號(hào)abs47027950
    規(guī)格50mg供貨周期現(xiàn)貨
    主要用途is a muscarinic acetylcholine receptor a應(yīng)用領(lǐng)域化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合

    Terconazole 67915-31-5

    產(chǎn)品描述
    描述
    Arecoline is a muscarinic acetylcholine receptor agonist. Arecoline induces ADP ribosylation of histones and chromatid relaxation in spleen and bone marrow cells.
    純度
    ≥98%
    儲(chǔ)存/保存方法
    Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
    基本信息
    別名
    特康唑;曲康唑;R42470
    外觀
    white powder
    可溶性/溶解性
    DMSO : ≥ 30 mg/mL (56.34 mM)
    生物活性
    In vitro(體外研究)
    Terconazole inhibits the growth of Candida albicans ATCC 44859 in a concentration-related manner, but with modest effects noted at levels from 0.1 to 10 μM when the yeast is grown on media favoring the cell form. The inhibitory potency of terconazole on yeast cell viability varies with the strain and species of Candida tested. The susceptibility of C. albicans ATCC 44859 to terconazole is markedly enhanced when the yeast is grown on Eagle minimum essential medium, which favors mycelium formation. There is a progression of changes, from loss of mycelia formation at 0.1 μM terconazole through complete necrosis at 100 μM. Terconazole blocks the morphogenetic transformation from the yeast into the filamentous form at concentrations of 0.008 to 0.05 microgram/mL.
    In vivo(體內(nèi)研究)
    A 3-day once-daily intravaginal application of terconazole 0.8% is usually sufficient to provide a functional therapeutic period of 7 days because of prolonged high biologically active antifungal levels in the vagina. No side effects are observed at any concentration of terconazole.
    參考文獻(xiàn)
    參考文獻(xiàn)
    研究領(lǐng)域
    研究領(lǐng)域
    MetabolismTypes of disease
    Drug DiscoverySmall Molecule DrugLead Compound Discovery
    Terconazole 67915-31-5溫馨提示:本產(chǎn)品僅作科研實(shí)驗(yàn)使用,不支持臨床等研究

    產(chǎn)品咨詢

    留言框

    • 產(chǎn)品:

    • 您的單位:

    • 您的姓名:

    • 聯(lián)系電話:

    • 常用郵箱:

    • 省份:

    • 詳細(xì)地址:

    • 補(bǔ)充說(shuō)明:

    • 驗(yàn)證碼:

      請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
    愛(ài)必信(上海)生物科技有限公司
    地址:上海市浦東新區(qū)新浩路58號(hào)申江科創(chuàng)園18棟
    傳真:
    關(guān)注我們
    歡迎您關(guān)注我們的微信公眾號(hào)了解更多信息:
    歡迎您關(guān)注我們的微信公眾號(hào)
    了解更多信息
    <th id="grzca"></th>
    <b id="grzca"><menuitem id="grzca"></menuitem></b>

    <th id="grzca"></th>
    <strong id="grzca"><form id="grzca"></form></strong>
  • <del id="grzca"><form id="grzca"></form></del>

    免费看a| 久久婷婷丁香五月综合 | 日本欧美国产在线 | 97国产超碰在线观看 | 久久色图|